-+ 0.00%
-+ 0.00%
-+ 0.00%

Artelo Biosciences Receives a Notice of Allowance from the U.S. Patent and Trademark Office for its Lead Investigational Drug Currently in Two Phase 2 Studies

Barchart·08/17/2026 07:52:00
Listen to the news

The Patent Claims are for the Intended Commercial Formulation of ART27.13

Expected to Extend Patent Protection for ART27.13 through 2041

Read more at globenewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.